Omalizumab

Aug 13, 2020

Novartis announces FDA filing acceptance of Xolair® (omalizumab) prefilled syringe for self-administration across all indications

Jun 12, 2020

Existing and Upcoming Therapies for Most Common Allergic, Infectious Diseases Including COVID-19

Apr 16, 2020

Study Finds Number of Asthma Biologic Medication Users and Spend Doubled Over 2.5 Years

Mar 18, 2020

GSK, AstraZeneca, Genentech, and Novartis Identified as the Top Companies Driving Therapeutic Innovation in Asthma